- Home
- AEON vs ATCX Comparison
AEON vs ATCX Comparison
Compare AEON & ATCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AEON | ATCX |
|---|---|---|
| Founded | N/A | 2016 |
| Country | United States | Brazil |
| Employees | 8 | 13 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8M | 23.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AEON | ATCX |
|---|---|---|
| Price | $0.92 | $5.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.20 | ★ $13.75 |
| AVG Volume (30 Days) | ★ 122.6K | 38.3K |
| Earning Date | 05-14-2026 | 03-16-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $827,667.00 |
| Revenue Next Year | N/A | $166.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.43 | $4.39 |
| 52 Week High | $1.45 | $14.01 |
Technical Indicators
Market Signals| Indicator | AEON | ATCX |
|---|---|---|
| Relative Strength Index (RSI) | 42.62 | 53.67 |
| Support Level | $0.91 | $4.66 |
| Resistance Level | $1.12 | $6.46 |
| Average True Range (ATR) | 0.08 | 0.35 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 15.63 | 79.80 |
Price Performance
Historical ComparisonAbout AEON AEON Biopharma Inc.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
About ATCX Atlas Critical Minerals Corporation Common Stock
Atlas Critical Minerals Corp is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.